Chromocell Therapeutics announced that its interim CEO Frank Knuettel, has been appointed as the company’s permanent CEO. Knuettel was previously appointed Interim CEO in July 2023, while currently serving as the company’s CFO, a role he will continue to fill for the near future.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CHRO:
- Chromocell Therapeutics Showcases Pipeline at Sidoti Conference
- Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
- Opening Day: Ride-hailing startup Ryde makes public debut
- Chromocell Therapeutics, Benuvia announce strategic partnership
- Chromocell Therapeutics Announces IPO and Restructuring Moves